Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01318564 · ClinicalTrials.gov registry record
Diabetic Treatment Adherence
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 28
- Enrollment target
NCT01318564: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01318564 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01318564 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to test an investigational type of packaging for diabetes drugs called "unit-dose packaging." Researchers want to learn if unit-dose packaging can help patients with Type II diabetes to take their drugs on the proper schedule.
Interventions
- DRUG Metformin
- BEHAVIORAL Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01318564
The ClinicalTrials.gov registry entry for NCT01318564 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Metformin is the first listed.
NCT01318564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01318564 about?
NCT01318564 is a clinical study titled "Diabetic Treatment Adherence". The goal of this clinical research study is to test an investigational type of packaging for diabetes drugs called "unit-dose packaging." Researchers want to learn if unit-dose packaging can help patients with Type II diabetes to take their drugs on the proper schedule.
What is the current status of trial NCT01318564?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2011-03. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01318564?
The interventions under investigation include: Metformin (DRUG), Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT01318564?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.